Standard Biotools Inc (LAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -77,875 | -32,157 | -74,656 | -54,880 | -33,883 |
| Depreciation Amortization | 4,506 | 2,534 | 13,919 | 10,953 | 7,137 |
| Accounts receivable | 5,012 | 686 | -2,991 | 677 | 2,238 |
| Accounts payable and accrued liabilities | -10,694 | -10,284 | 1,618 | -484 | -1,774 |
| Other Working Capital | -26,523 | -22,498 | -1,972 | 594 | -131 |
| Other Operating Activity | 4,048 | -757 | 20,795 | 13,914 | 8,599 |
| Operating Cash Flow | $-101,526 | $-62,476 | $-43,287 | $-29,226 | $-17,814 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 91,016 | 38,823 | 23,068 | 36,107 | 85,128 |
| PPE Investments | -2,718 | -781 | -2,831 | -2,753 | -1,848 |
| Net Acquisitions | 280,033 | 280,033 | N/A | N/A | N/A |
| Investing Cash Flow | $368,331 | $318,075 | $20,237 | $33,354 | $83,280 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -8,192 | -8,192 | -2,083 | -833 | N/A |
| Common Stock Issued | 1,477 | 72 | 827 | 406 | 326 |
| Common Stock Repurchased | -40,490 | -11,051 | -5,414 | -5,240 | -4,841 |
| Other Financing Activity | -889 | -562 | -139 | -139 | -127 |
| Financing Cash Flow | $-48,094 | $-19,733 | $-6,809 | $-5,806 | $-4,642 |
| Exchange Rate Effect | -110 | -21 | 34 | -196 | -49 |
| Beginning Cash Position | 52,499 | 52,499 | 82,324 | 82,324 | 82,324 |
| End Cash Position | 271,100 | 288,344 | 52,499 | 80,450 | 143,099 |
| Net Cash Flow | $218,601 | $235,845 | $-29,825 | $-1,874 | $60,775 |
| Free Cash Flow | |||||
| Operating Cash Flow | -101,526 | -62,476 | -43,287 | -29,226 | -17,814 |
| Capital Expenditure | -2,718 | -781 | -2,831 | -2,753 | -1,848 |
| Free Cash Flow | -104,244 | -63,257 | -46,118 | -31,979 | -19,662 |